Company: OCEA
Filing Date: 2025-08-05
Form Type: 8-K
Source: 0001641172-25-022271
Chunk: 0

Company: Ocean Biomedical, Inc.
Filing Date: 2025-08-05
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On
July 31, 2025, the Company was notified by Nasdaq that The Nasdaq Stock Market LLC Board of Directors has declined to call for review
the May 15, 2025 decision of the Nasdaq Listing and Hearing Review Council (the “ Listing Council”) in the Company’s
appeal proceding. Accordingly, pursuant to Nasdaq Rule 5820(e)(6), the decision of the Listing Council represents Nasdaq’s final
action in this matter. Nasdaq will follow the procedures contained in Nasdaq Rule 5830 and the Securities and Exchange Commission (“ SEC”)
Rule 12d2-2 to remove the Company’s securities from listing.

Item
5.02 Resignation of Director and Officer